Eight-week healing of grafted calvarial bone defects with hyperbaric oxygen therapy in rats
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The purpose of this study was to evaluate the synergistic effect of adjunctive hyperbaric oxygen (HBO) therapy on new bone formation and angiogenesis after 8 weeks of healing. Methods: Sprague-Dawley rats (n=28) were split into 2 groups according to the application of adjunctive HBO therapy: a group that received HBO therapy (HBO group [n=14]) and another group that did not receive HBO therapy (NHBO group [n=14]). Each group was divided into 2 subgroups according to the type of bone graft material: a biphasic calcium phosphate (BCP) subgroup and an Escherichia coli-derived recombinant human bone morphogenetic protein-2-/epigallocatechin-3-gallate-coated BCP (mBCP) subgroup. Two identical circular defects with a 6-mm diameter were made in the right and left parietal bones of each rat. One defect was grafted with bone graft material (BCP or mBCP). The other defect was not grafted. The HBO group received 2 weeks of adjunctive HBO therapy (1 hour, 5 times a week). The rats were euthanized 8 weeks after surgery. The specimens were prepared for histologic analysis. Results: New bone (%) was higher in the NHBO-mBCP group than in the NHBO-BCP and control groups (P<0.05). Blood vessel count (%) and vascular endothelial growth factor staining (%) were higher in the HBO-mBCP group than in the NHBO-mBCP group (P<0.05). Conclusions: HBO therapy did not have a positive influence on bone formation irrespective of the type of bone graft material applied after 8 weeks of healing. HBO therapy had a positive effect on angiogenic activity.
Abstract
Purpose: The purpose of this study was to evaluate the synergistic effect of adjunctive hyperbaric oxygen (HBO) therapy on new bone formation and angiogenesis after 8 weeks of healing. Methods: Sprague-Dawley rats (n=28) were split into 2 groups according to the application of adjunctive HBO therapy: a group that received HBO therapy (HBO group [n=14]) and another group that did not receive HBO therapy (NHBO group [n=14]). Each group was divided into 2 subgroups according to the type of bone graft material: a biphasic calcium phosphate (BCP) subgroup and an Escherichia coli-derived recombinant human bone morphogenetic protein-2-/epigallocatechin-3-gallate-coated BCP (mBCP) subgroup. Two identical circular defects with a 6-mm diameter were made in the right and left parietal bones of each rat. One defect was grafted with bone graft material (BCP or mBCP). The other defect was not grafted. The HBO group received 2 weeks of adjunctive HBO therapy (1 hour, 5 times a week). The rats were euthanized 8 weeks after surgery. The specimens were prepared for histologic analysis. Results: New bone (%) was higher in the NHBO-mBCP group than in the NHBO-BCP and control groups (P<0.05). Blood vessel count (%) and vascular endothelial growth factor staining (%) were higher in the HBO-mBCP group than in the NHBO-mBCP group (P<0.05). Conclusions: HBO therapy did not have a positive influence on bone formation irrespective of the type of bone graft material applied after 8 weeks of healing. HBO therapy had a positive effect on angiogenic activity.
참고문헌 (30)
- Dauwe PB, "Does hyperbaric oxygen therapy work in facilitating acute wound healing: a systematic review", Plast Reconstr Surg, 133, pp.208e~215e (2014)
- Tibbles PM, "Hyperbaric-oxygen therapy", N Engl J Med, 334, pp.1642~1648 (1996)
- Howard MA, "Oxygen and wound care: a review of current therapeutic modalities and future direction", Wound Repair Regen, 21, pp.503~511 (2013)
- Hopf HW, "Hyperoxia and angiogenesis", Wound Repair Regen, 13, pp.558~564 (2005)
- Jan AM, "Hyperbaric oxygen results in an increase in rabbit calvarial critical sized defects", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 101, pp.144~149 (2006)
- Jan A, "Effect of hyperbaric oxygen on grafted and nongrafted calvarial critical-sized defects", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 107, pp.157~163 (2009)
- Pedersen TO, "Hyperbaric oxygen stimulates vascularization and bone formation in rat calvarial defects", Int J Oral Maxillofac Surg, 42, pp.907~914 (2013)
- 장혜윤, "Four-week histologic evaluation of grafted calvarial defects with adjunctive hyperbaric oxygen therapy in rats", Journal of Periodontal & Implant Science, 46(4), pp.244~253 (2016), 대한치주과학회
- Laurencin C, "Bone graft substitutes", Expert Rev Med Devices, 3, pp.49~57 (2006)
- Palti A, "A concept for the treatment of various dental bone defects", Implant Dent, 11, pp.73~78 (2002)
- Kim S, "Effects of biphasic calcium phosphate bone substitute on circumferential bone defects around dental implants in dogs", Int J Oral Maxillofac Implants, 26, pp.265~273 (2011)
- 최현민, "Improvement of osteogenic potential of biphasic calcium phosphate bone substitute coated with two concentrations of expressed recombinant human bone morphogenetic protein 2", Journal of Periodontal & Implant Science, 42(4), pp.119~126 (2012), 대한치주과학회[DOI]
- Shin YS, "The effects of ErhBMP-2-", EGCG-coated BCP bone substitute on dehiscence around dental implants in dogs, 2014, pp.20, 281~287
- Wong DA, "Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF", TLIF use of bone morphogenetic protein-2 (BMP2), 2008, pp.8, 1011~1018
- Kaneko H, "Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts", Bone, 27, pp.479~486 (2000)
- Smucker JD, "Increased swelling complications associated with offlabel usage of rhBMP-2 in the anterior cervical spine", Spine, 31, pp.2813~2819 (2006)
- Jin P, "Epigallocatechin-3-gallate (EGCG) as a pro-osteogenic agent to enhance osteogenic differentiation of mesenchymal stem cells from human bone marrow: an in vitro study", Cell Tissue Res, 356, pp.381~390 (2014)
- Oka Y, "Tea polyphenols inhibit rat osteoclast formation and differentiation", J Pharmacol Sci, 118, pp.55~64 (2012)
- Xiao SJ, "Covalent attachment of cell-adhesive, (Arg-Gly-Asp)-containing peptides to titanium surfaces", Langmuir, 14, pp.5507~5516 (1998)
- Durrieu MC, "Grafting RGD containing peptides onto hydroxyapatite to promote osteoblastic cells adhesion", J Mater Sci Mater Med, 15, pp.779~786 (2004)
- Jan A, "Effect of hyperbaric oxygen on demineralized bone matrix and biphasic calcium phosphate bone substitutes", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, pp.59~66 (2010)
- Sirin Y, "The influence of hyperbaric oxygen treatment on the healing of experimental defects filled with different bone graft substitutes", Int J Med Sci, 8, pp.114~125 (2011)
- Develıoğlu H, "Assessment of the effect of a biphasic ceramic on bone response in a rat calvarial defect model", J Biomed Mater Res A, 77A, pp.627~631 (2006)
- Sawai T, "Histologic study of the effect of hyperbaric oxygen therapy on autogenous free bone grafts", J Oral Maxillofac Surg, 54, pp.975~981 (1996)
- Fok TC, "Hyperbaric oxygen results in increased vascular endothelial growth factor (VEGF) protein expression in rabbit calvarial critical-sized defects", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 105, pp.417~422 (2008)
- Gosain AK, "Osteogenesis in cranial defects:reassessment of the concept of critical size and the expression of TGF-beta isoforms", Plast Reconstr Surg, 106, pp.360~371 (2000)
- Cooper GM, "Testing the critical size in calvarial bone defects: revisiting the concept of a critical-size defect", Plast Reconstr Surg, 125, pp.1685~1692 (2010)
- Dånmark S, "Osteogenic differentiation by rat bone marrow stromal cells on customized biodegradable polymer scaffolds", J Bioact Compat Polym, 25, pp.207~223 (2010)
- Mardas N, "Bone and suture regeneration in calvarial defects by e-PTFEmembranes and demineralized bone matrix and the impact on calvarial growth: an experimental study in the rat", J Craniofac Surg, 13, pp.453~462 (2002)
- Humber CC, "Bone healing with an in situformed bioresorbable polyethylene glycol hydrogel membrane in rabbit calvarial defects", Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 109, pp.372~384 (2010)